SCHEMBL27355138

SCHEMBL27355138

CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCN(C)C

nearest known ligand 0.84

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 3/20 0.68
PRKCE Q02156 2/20 0.68
PRKCQ Q04759 2/20 0.68
PRKCD Q05655 2/20 0.68
ALDH1A1 P00352 2/20 0.63
LMNA P02545 1/20 0.63
SELP P16109 1/20 0.62
FAAH O00519 3/20 0.58
MAPT P10636 1/20 0.58
HPGD P15428 1/20 0.58
CNR1 P21554 1/20 0.58
CNR2 P34972 1/20 0.58
S1PR1 P21453 1/20 0.56
NR5A2 O00482 1/20 0.55
NR5A1 Q13285 1/20 0.55
DGKA P23743 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26122535 1.00 PRKCA (0.68) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL24614919 1.00 PRKCA (0.68) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL24615031 0.96 PRKCA (0.70) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL8019539 0.96 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL8019543 0.96 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL8014266 0.96 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL8020614 0.96 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL8014269 0.96 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL8020619 0.96 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL8013208 0.96 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023201097-A1 METHODS AND COMPOSITIONS FOR IMMUNE CELL REJUVENATION AND THERAPIES USING REJUVENATED IMMUNE CELLS TURN BIOTECHNOLOGIES, INC. (US) 2023-10-19 WO disclosed